These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 1353874)
1. [Serotonin agonists and antagonists in migraine]. Ollat H Pathol Biol (Paris); 1992 Apr; 40(4):389-96. PubMed ID: 1353874 [TBL] [Abstract][Full Text] [Related]
2. [Improper equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System]. Ferrari MD; Haan J; Bax WA; van Coevorden RS; Timmerman H; Meijler WJ Ned Tijdschr Geneeskd; 1993 Apr; 137(17):846-50. PubMed ID: 8387648 [No Abstract] [Full Text] [Related]
3. Acute and prophylactic treatment of migraine: practical approaches and pharmacologic rationale. Raskin NH Neurology; 1993 Jun; 43(6 Suppl 3):S39-42. PubMed ID: 8389010 [TBL] [Abstract][Full Text] [Related]
4. [Unjustified equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System]. Van Mil JW Ned Tijdschr Geneeskd; 1993 Jun; 137(24):1213-4. PubMed ID: 8391659 [No Abstract] [Full Text] [Related]
7. The animal pharmacology of drugs used in the treatment of migraine. Fozard JR J Pharm Pharmacol; 1975 May; 27(5):297-321. PubMed ID: 239131 [No Abstract] [Full Text] [Related]
8. SUMATRIPTAN: a receptor-targeted treatment for migraine. Moskowitz MA; Cutrer FM Annu Rev Med; 1993; 44():145-54. PubMed ID: 8386498 [TBL] [Abstract][Full Text] [Related]
9. Ergotamine and dihydroergotamine: history, pharmacology, and efficacy. Silberstein SD; McCrory DC Headache; 2003 Feb; 43(2):144-66. PubMed ID: 12558771 [TBL] [Abstract][Full Text] [Related]
11. [The treatment of migraine]. Titus F Rev Neurol; 1997 Feb; 25(138):295-300. PubMed ID: 9147762 [No Abstract] [Full Text] [Related]
12. Potentiation and antagonism of serotonin effects on intracranial and extracranial vessels. Possible implications in migraine. Hardebo JE; Edvinsson L; Owman C; Svendgaard NA Neurology; 1978 Jan; 28(1):64-70. PubMed ID: 563539 [TBL] [Abstract][Full Text] [Related]
13. Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment. Dahlöf C; Maassen Van Den Brink A Headache; 2012 Apr; 52(4):707-14. PubMed ID: 22444161 [TBL] [Abstract][Full Text] [Related]
14. The trigemino-vascular system and migraine. Buzzi MG; Moskowitz MA Pathol Biol (Paris); 1992 Apr; 40(4):313-7. PubMed ID: 1379707 [TBL] [Abstract][Full Text] [Related]
15. Sumatriptan and other drugs used in migraine treatment. Green C Aust Nurses J; 1992 Jul; 22(1):27-9. PubMed ID: 1356332 [No Abstract] [Full Text] [Related]
16. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine. Buzzi MG; Moskowitz MA Cephalalgia; 1991 Sep; 11(4):165-8. PubMed ID: 1660351 [TBL] [Abstract][Full Text] [Related]
17. New "triptans" and other drugs for migraine. Med Lett Drugs Ther; 1998 Oct; 40(1037):97-100. PubMed ID: 9793036 [No Abstract] [Full Text] [Related]
18. [Mechanism of action of drugs currently used in the prevention of migraine]. Fanchamps A Minerva Med; 1976 Jun; 67(28):1858-60. PubMed ID: 59325 [TBL] [Abstract][Full Text] [Related]